<table id="t6" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 6: Clinically Significant Drug Interactions with BASAGLAR
</caption>
<col align="left" width="24.150%"></col>
<col align="left" width="75.850%"></col>
<tbody>
<tr>
<td align="left" colspan="2" stylecode="Toprule Botrule Lrule Rrule" valign="top">
<content stylecode="bold">Drugs That May Increase the Risk of Hypoglycemia</content>
</td>
</tr>
<tr>
<td align="right" stylecode="Botrule Lrule Rrule" valign="middle">
<content stylecode="italics">Drugs:</content>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, propoxyphene, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics.
</td>
</tr>
<tr>
<td align="right" stylecode="Botrule Lrule Rrule" valign="middle">
<content stylecode="italics">Intervention:</content>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Dose reductions and increased frequency of glucose monitoring may be required when BASAGLAR is co-administered with these drugs.
</td>
</tr>
<tr>
<td align="left" colspan="2" stylecode="Botrule Lrule Rrule" valign="top">
<content stylecode="bold">Drugs That May Decrease the Blood Glucose Lowering Effect of BASAGLAR</content>
</td>
</tr>
<tr>
<td align="right" stylecode="Botrule Lrule Rrule" valign="middle">
<content stylecode="italics">Drugs:</content>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Atypical antipsychotics (e.g., olanzapine and clozapine), corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens (e.g., in oral contraceptives), protease inhibitors, somatropin, sympathomimetic agents (e.g., albuterol, epinephrine, terbutaline), and thyroid hormones
</td>
</tr>
<tr>
<td align="right" stylecode="Botrule Lrule Rrule" valign="middle">
<content stylecode="italics">Intervention:</content>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Dose increases and increased frequency of glucose monitoring may be required when BASAGLAR is co-administered with these drugs.
</td>
</tr>
<tr>
<td align="left" colspan="2" stylecode="Botrule Lrule Rrule" valign="top">
<content stylecode="bold">Drugs That May Increase or Decrease the Blood Glucose Lowering Effect of BASAGLAR</content>
</td>
</tr>
<tr>
<td align="right" stylecode="Botrule Lrule Rrule" valign="middle">
<content stylecode="italics">Drugs:</content>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Alcohol, beta-blockers, clonidine, and lithium salts. Pentamidine may cause hypoglycemia, which may sometimes be followed by hyperglycemia.
</td>
</tr>
<tr>
<td align="right" stylecode="Botrule Lrule Rrule" valign="middle">
<content stylecode="italics">Intervention:</content>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Dose adjustment and increased frequency of glucose monitoring may be required when BASAGLAR is co-administered with these drugs.
</td>
</tr>
<tr>
<td align="left" colspan="2" stylecode="Botrule Lrule Rrule" valign="top">
<content stylecode="bold">Drugs That May Blunt Signs and Symptoms of Hypoglycemia</content>
</td>
</tr>
<tr>
<td align="right" stylecode="Botrule Lrule Rrule" valign="top">
<content stylecode="italics">Drugs:</content>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">beta-blockers, clonidine, guanethidine, and reserpine
</td>
</tr>
<tr>
<td align="right" stylecode="Botrule Lrule Rrule" valign="middle">
<content stylecode="italics">Intervention:</content>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Increased frequency of glucose monitoring may be required when BASAGLAR is co-administered with these drugs.
</td>
</tr>
</tbody>
</table>